Aquestive Therapeutics, Inc. (AQST): Cash & Equivalents
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2020-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$31.81M
As of 2020-12-31
$98.49M
As of 2026-06-30
+22.3%
3-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2020-12-31 | $31.81M | -35.5% | 2021-03-09, Balance as of period end |
| 2019-12-31 | $49.33M | -18.6% | 2021-03-09, Balance as of period end |
| 2018-12-31 | $60.60M | +248.7% | 2020-03-11, Balance as of period end |
| 2017-12-31 | $17.38M | n/a | 2019-03-14, Balance as of period end |